glp 1 drugs news The promises and pitfalls of GLP-1 Medicare will now help pay

If someone uses a four-peptide blend and reports an effect better or worse there is no way to know which ingredient (or interaction, or placebo response, or concurrent training and diet) produced it

A strategic peptide combination engineered to enhance gh release through synchronized GHRH and ghrelin receptor activation in experimental research models

Stronger conclusions can be drawn from topical and wound-related studies than from injectable or systemic anti-aging claims

IL-20 also caused tubular epithelial cells to die and increased mesangial cells production of pro-inflammatory molecules

No notable impact on blood glucose, cholesterol, or blood pressure has been observed in shortterm studies (glucose tolerance findings)

I'm Andrew Huberman, and I'm a professor of neurobiology and ophthalmology at Stanford School of Medicine